Cargando…
Influence of SGLT2 Inhibitor Treatment on Urine Antioxidant Status in Type 2 Diabetic Patients: A Pilot Study
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have been recognized as potent antioxidant agents. Since SGLT2i are nephroprotective drugs, we aimed to examine the urine antioxidant status in patients with type 2 diabetes mellitus (T2DM). One hundred and one subjects participated in this study, i...
Autores principales: | Nabrdalik-Leśniak, Diana, Nabrdalik, Katarzyna, Sedlaczek, Katarzyna, Główczyński, Patryk, Kwiendacz, Hanna, Sawczyn, Tomasz, Hajzler, Weronika, Drożdż, Karolina, Hendel, Mirela, Irlik, Krzysztof, Stelmach, Paweł, Adamczyk, Piotr, Paradysz, Andrzej, Kasperczyk, Sławomir, Stompór, Tomasz, Gumprecht, Janusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294983/ https://www.ncbi.nlm.nih.gov/pubmed/34336104 http://dx.doi.org/10.1155/2021/5593589 |
Ejemplares similares
-
Metabolic-Associated Fatty Liver Disease (MAFLD), Diabetes, and Cardiovascular Disease: Associations with Fructose Metabolism and Gut Microbiota
por: Drożdż, Karolina, et al.
Publicado: (2021) -
A Multicenter, Prospective, Observational, Open-Label Study of the Safety and Comfort of Gensulin(®) Delivery Device Use in a Large Cohort of Adult and Elderly Patients with Type 2 Diabetes
por: Masierek, Małgorzata, et al.
Publicado: (2020) -
Fat, Sugar or Gut Microbiota in Reducing Cardiometabolic Risk: Does Diet Type Really Matter?
por: Nabrdalik, Katarzyna, et al.
Publicado: (2021) -
Inflammation and Oxidative Stress in Diabetic Kidney Disease: The Targets for SGLT2 Inhibitors and GLP-1 Receptor Agonists
por: Winiarska, Agata, et al.
Publicado: (2021) -
Low Quantitative Blush Evaluator score predicts larger infarct size and reduced left ventricular systolic function in patients with STEMI regardless of diabetes status
por: Nabrdalik, Katarzyna, et al.
Publicado: (2023)